Control of Sleep and Wakefulness in Health and Disease - Progress in Molecular Biology and Translational Science - page 151

23. Hallanger AE, Levey AI, Lee HJ, Rye DB, Wainer BH. The origins of cholinergic and
other subcortical afferents to the thalamus in the rat. J Comp Neurol . 1987;262:105-124.
24. Rye DB, Wainer BH, MesulamMM, Mufson EJ, Saper CB. Cortical projections arising
from the basal forebrain: a study of cholinergic and noncholinergic components
employing combined retrograde tracing and immunohistochemical localization of cho-
line acetyltransferase. Neuroscience . 1984;13:627-643.
25. Jones BE. Modulation of cortical activation and behavioral arousal by cholinergic and
orexinergic systems. Ann N Y Acad Sci . 2008;1129:26-34.
26. Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer's disease: epide-
miology, pathophysiology and treatment. CNS Drugs . 2001;15:777-796.
27. Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R. Predictors of institutionalization for
people with dementia living at home with a carer. Int J Geriatr Psychiatry . 1998;13:682-690.
28. Yaffe K, Fox P, Newcomer R, et al. Patient and caregiver characteristics and nursing
home placement in patients with dementia. JAMA . 2002;287:2090-2097.
29. Swaab DF, Fliers E, Partiman TS. The suprachiasmatic nucleus of the human brain in
relation to sex, age and senile dementia. Brain Res . 1985;342:37-44.
30. Friedman L, Zeitzer JM, Kushida CA, et al. Scheduled bright light for treatment of
insomnia in older adults. J Am Geriatr Soc . 2009;57:441-452.
31. Buysse DJ, Browman KE, Monk TH, Reynolds III CF, Fasiczka AL, Kupfer DJ. Nap-
ping and 24-hour sleep/wake patterns in healthy elderly and young adults. J Am Geriatr
Soc . 1992;40:779-786.
32. Klerman EB, Dijk DJ. Age-related reduction in the maximal capacity for sleep—
implications for insomnia. Curr Biol . 2008;18:1118-1123.
33. Westerberg CE, Lundgren EM, Florczak SM, et al. Sleep influences the severity of mem-
ory disruption in amnestic mild cognitive impairment: results from sleep self-assessment
and continuous activity monitoring. Alzheimer Dis Assoc Disord . 2010;24:325-333.
34. Von Economo C. Encephalitis Lethargica: Its Sequelae and Treatment. London: Oxford
University Press; 1931.
35. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a
generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med .
2000;6:991-997.
36. Kornum BR, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infec-
tions and autoimmunity of the brain. Curr Opin Neurobiol . 2011;21:897-903.
37. Aran A, Lin L, Nevsimalova S, et al. Elevated anti-streptococcal antibodies in patients
with recent narcolepsy onset. Sleep . 2009;32:979-983.
38. Dauvilliers Y, Montplaisir J, Cochen V, et al. Post-H1N1 narcolepsy-cataplexy. Sleep .
2010;33:1428-1430.
39. Salomon RM, Ripley B, Kennedy JS, et al. Diurnal variation of CSF hypocretin-1
(orexin-A) levels in control and depressed subjects. Biol Psychiatry . 2003;54:96-104.
40. Zeitzer JM, Buckmaster CL, Parker KJ, Hauck CM, Lyons DM, Mignot E. Circadian
and homeostatic regulation of hypocretin in a primate model: implications for the con-
solidation of wakefulness. J Neurosci . 2003;23:3555-3560.
41. Zeitzer JM, Mignot E. Role of hypocretin/orexin in the neurobiology of sleep and alert-
ness. In: Bassetti C, Billiard M, Mignot E, eds. Narcolepsy and Hypersomnia . New York:
Informa Healthcare; 2006:359-374.
42. Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneu-
rons. J Neurosci . 2004;24:5336-5345.
43. Borb´ly AA. A two process model of sleep regulation. Hum Neurobiol . 1982;1:195-204.
44. Dijk D-J, Czeisler CA. Paradoxical timing of the circadian rhythm of sleep propensity
serves to consolidate sleep and wakefulness in humans. Neurosci Lett . 1994;166:63-68.
45. Cooper SJ. From Claude Bernard to Walter Cannon. Emergence of the concept of
homeostasis. Appetite . 2008;51:419-427.